{"@context":{"@vocab":"https://schema.org/"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/fda/warning-letters/check?name=Innoveix%20Pharmaceuticals%20Inc","name":"Innoveix Pharmaceuticals Inc","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters","generated_at":"2026-10-05T10:05:07.707Z"},"count":1,"matches":[{"id":"cdd003798242fe98","posted_date":"2022-02-08","letter_issue_date":"2022-01-26","company_name":"Innoveix Pharmaceuticals Inc","issuing_office":"Office of Pharmaceutical Quality Operations, Division II","subject":"Compounding Pharmacy/Adulterated Drug Products","canonical_url":"https://api.morvs.ai/fda-warning/cdd003798242fe98"}]}